A New Look for the Ragon Institute

Date: February 9, 2023 By: Emily Makowski

Collaborate. Research. Cure. These three words embody the spirit of what we represent at the Ragon Institute of Mass General, MIT, and Harvard.

We’re proud to announce our new logo — and tagline — as part of an institute-wide rebrand ahead of the opening of our new building next year!

Our updated visual identity combines elements of unity, collaboration, and clarity to create an intelligent framework for conveying our mission and vision. It demonstrates the Institute’s continued connection to the brilliant teams and individuals at Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, and also represents our boldness in targeting the most intractable diseases — such as HIV, tuberculosis, and malaria — with the power of cutting-edge scientific research.

While the look and feel of our brand may be different moving forward, the Ragon Institute is more committed than ever to realizing our goals of leveraging cross-disciplinary collaboration to transform human health on a global scale; developing and deploying novel scientific research to improve health and care outcomes; and harnessing the immune system to prevent and cure human disease.

Join us in celebrating the launch of our new brand as we look forward to a more innovative and successful future. Together, we can work to overcome the toughest health challenges facing our world today.

More News

“A Wonderful Opportunity” – An Interview with Ragon Postdoc and Ramón Areces Foundation Research Fellow Gema González Rubio

González Rubio discusses the circumstances that brought her to the Ragon and how she hopes to grow from it

Press Releases

Ragon Study Reveals Critical Insights into RSV Immunity in Infants

Postdoctoral fellow Nadège Nziza was the first author of the study, published in Immunity, which explores how the immune responses of infants to RSV change over time.

Press Releases

HARVARD GAZETTE – How Ragon Institute’s new home aids mission

Immunology focus expands to neurodegenerative diseases and other areas as collaboration between Harvard, MIT, and Mass. General Hospital turns 15